Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Epstein

Showing results (881-890 of 1,132) with videos related to

Pageof 114
Sort By:
BJU International|June 11, 2013
Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA densityMartin H Umbehr, Elizabeth A Platz, Sarah B Peskoe, et al.
Archives of Pathology & Laboratory Medicine|July 31, 2010
Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic centerHiroshi Miyamoto, Fadi Brimo, Luciana Schultz, et al.
Frontiers in Bioscience : a Journal and Virtual Library|April 18, 2003
Membrane and synaptic effects of anti-S-100 are prevented by the same antibodies in low concentrationsO I Epstein, A Beregovoy, N S Sorokina, et al.
BJU International|September 10, 2016
Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective seriesMark W Ball, Kelly T Harris, Zeyad R Schwen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2013
Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stageCarla L Ellis, John N Eble, Andrea P Subhawong, et al.
Cancer Research|August 15, 1996
An uncertain role for p53 gene alterations in human prostate cancersJ D Brooks, G S Bova, C M Ewing, et al.
Urology|August 3, 2023
Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) Magnetic Resonance Imaging Scoring to Predict Clinical Outcomes in Active Surveillance for Grade Group 1 Prostate CancerYasin Bhanji, Mufaddal Mamawala, Claire M de la Calle, et al.
The American Journal of Surgical Pathology|September 9, 1999
Renal oncocytosis: a morphologic study of fourteen casesS K Tickoo, V E Reuter, M B Amin, et al.
Urology|May 1, 1994
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesA W Partin, J D Pearson, P K Landis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Implication of cell kinetic changes during the progression of human prostatic cancerR R Berges, J Vukanovic, J I Epstein, et al.
Pageof 114

Showing results (881-890 of 1,132) with videos related to

Sort By:
Pageof 114
BJU International|June 11, 2013
Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA densityMartin H Umbehr, Elizabeth A Platz, Sarah B Peskoe, et al.
Archives of Pathology & Laboratory Medicine|July 31, 2010
Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic centerHiroshi Miyamoto, Fadi Brimo, Luciana Schultz, et al.
Frontiers in Bioscience : a Journal and Virtual Library|April 18, 2003
Membrane and synaptic effects of anti-S-100 are prevented by the same antibodies in low concentrationsO I Epstein, A Beregovoy, N S Sorokina, et al.
BJU International|September 10, 2016
Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective seriesMark W Ball, Kelly T Harris, Zeyad R Schwen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2013
Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stageCarla L Ellis, John N Eble, Andrea P Subhawong, et al.
Cancer Research|August 15, 1996
An uncertain role for p53 gene alterations in human prostate cancersJ D Brooks, G S Bova, C M Ewing, et al.
Urology|August 3, 2023
Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) Magnetic Resonance Imaging Scoring to Predict Clinical Outcomes in Active Surveillance for Grade Group 1 Prostate CancerYasin Bhanji, Mufaddal Mamawala, Claire M de la Calle, et al.
The American Journal of Surgical Pathology|September 9, 1999
Renal oncocytosis: a morphologic study of fourteen casesS K Tickoo, V E Reuter, M B Amin, et al.
Urology|May 1, 1994
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesA W Partin, J D Pearson, P K Landis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Implication of cell kinetic changes during the progression of human prostatic cancerR R Berges, J Vukanovic, J I Epstein, et al.
Pageof 114